Abstract:Purpose: Artificial intelligence-based tools can be leveraged to improve detection and segmentation of brain metastases for stereotactic radiosurgery (SRS). VBrain by Vysioneer Inc. is a deep learning algorithm with recent FDA clearance to assist in brain tumor contouring. We aimed to assess the performance of this tool by various demographic and clinical characteristics among patients with brain metastases treated with SRS. Materials and methods: We randomly selected 100 patients with brain metastases who underwent initial SRS on the CyberKnife from 2017 to 2020 at a single institution. Cases with resection cavities were excluded from the analysis. Computed tomography (CT) and axial T1-weighted post-contrast magnetic resonance (MR) image data were extracted for each patient and uploaded to VBrain. A brain metastasis was considered "detected" when the VBrain- "predicted" contours overlapped with the corresponding physician contours ("ground-truth" contours). We evaluated performance of VBrain against ground-truth contours using the following metrics: lesion-wise Dice similarity coefficient (DSC), lesion-wise average Hausdorff distance (AVD), false positive count (FP), and lesion-wise sensitivity (%). Kruskal-Wallis tests were performed to assess the relationships between patient characteristics including sex, race, primary histology, age, and size and number of brain metastases, and performance metrics such as DSC, AVD, FP, and sensitivity. Results: We analyzed 100 patients with 435 intact brain metastases treated with SRS. Our cohort consisted of patients with a median number of 2 brain metastases (range: 1 to 52), median age of 69 (range: 19 to 91), and 50% male and 50% female patients. The primary site breakdown was 56% lung, 10% melanoma, 9% breast, 8% gynecological, 5% renal, 4% gastrointestinal, 2% sarcoma, and 6% other, while the race breakdown was 60% White, 18% Asian, 3% Black/African American, 2% Native Hawaiian or other Pacific Islander, and 17% other/unknown/not reported. The median tumor size was 0.112 c.c. (range: 0.010-26.475 c.c.). We found mean lesion-wise DSC to be 0.723, mean lesion-wise AVD to be 7.34% of lesion size (0.704 mm), mean FP count to be 0.72 tumors per case, and lesion-wise sensitivity to be 89.30% for all lesions. Moreover, mean sensitivity was found to be 99.07%, 97.59%, and 96.23% for lesions with diameter equal to and greater than 10 mm, 7.5 mm, and 5 mm, respectively. No other significant differences in performance metrics were observed across demographic or clinical characteristic groups. Conclusion: In this study, a commercial deep learning algorithm showed promising results in segmenting brain metastases, with 96.23% sensitivity for metastases with diameters of 5 mm or higher. As the software is an assistive AI, future work of VBrain integration into the clinical workflow can provide further clinical and research insights.

An Artificial Intelligence Framework for Automatic Segmentation and Volumetry of Vestibular Schwannomas from Contrast-Enhanced T1-weighted and High-Resolution T2-weighted MRI.

Segmentation of Vestibular Schwannoma from MRI — an Open Annotated Dataset and Baseline Algorithm

Deep Learning for Automatic Segmentation of Vestibular Schwannoma: A Retrospective Study from Multi-Centre Routine MRI

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Deep Learning-Based Automatic Segmentation for Size and Volumetric Measurement of Breast Cancer on Magnetic Resonance Imaging.

Deep learning for automatic segmentation of vestibular schwannoma: a retrospective study from multi-center routine MRI

Automatic Segmentation of Vestibular Schwannoma from T2-Weighted MRI by Deep Spatial Attention with Hardness-Weighted Loss

Automatic Segmentation of Vestibular Schwannomas: A Systematic Review

An External Validation Study for Automated Segmentation of Vestibular Schwannoma

Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery

Development and Validation of a Fully Automatic Tissue Delineation Model for Brain Metastasis Using a Deep Neural Network.

A Clinical Guideline Driven Automated Linear Feature Extraction for Vestibular Schwannoma

Quantification of tumor response of cystic vestibular schwannoma to Gamma Knife radiosurgery by using artificial intelligence

Fully Automated MRI Segmentation and Volumetric Measurement of Intracranial Meningioma Using Deep Learning

Learning-Based Automatic Segmentation of Arteriovenous Malformations on Contrast CT Images in Brain Stereotactic Radiosurgery

Information Maximized U-Nets for Vestibular Schwannoma Segmentation Using MRI with Missing Modality

Accuracy of vestibular schwannoma segmentation using deep learning models - a systematic review & meta-analysis

Automatic Brain Arteriovenous Malformations Segmentation on Contrast CT Images Using Combined Region Proposal Network and V-Net.

Automated volumetry of meningiomas in contrast-enhanced T1-Weighted MRI using deep learning

P13.02.B Fully automated segmentation and volumetric measurement of intracranial meningioma using deep learning

Sliding transformer with uncertainty estimation for vestibular schwannoma automatic segmentation